[Federal Register Volume 76, Number 236 (Thursday, December 8, 2011)]
[Notices]
[Page 76802]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-31548]


-----------------------------------------------------------------------

SMALL BUSINESS ADMINISTRATION

[License No. 02/02-0646]


Riverside Micro-Cap Fund II, L.P.; Notice Seeking Exemption Under 
Section 312 of the Small Business Investment Act, Conflicts of Interest

    Notice is hereby given that Riverside Micro-Cap Fund II, L.P., 45 
Rockefeller Center, New York, NY 10111, a Federal Licensee under the 
Small Business Investment Act of 1958, as amended (``the Act''), in 
connection with the financing of a small concern, has sought an 
exemption under Section 312 of the Act and Section 107.730, Financings 
which Constitute Conflicts of Interest of the Small Business 
Administration (``SBA'') Rules and Regulations (13 CFR 107.730). 
Riverside Micro-Cap Fund II, L.P. proposes to provide equity security 
financing to DrugTest Holding Company, 12600 Northborough Drive, Suite 
300, Houston, TX 77067 (``DISA'').
    The financing is brought within the purview of Sec.  107.730(a) and 
(d) of the Regulations because Riverside Capital Appreciation Fund V, 
L.P. and Co-Invest Vehicle, both Associates of Riverside Micro-Cap Fund 
II, L.P., own more than ten percent of DISA, and therefore this 
transaction is considered a financing of an Associate requiring prior 
SBA approval.
    Notice is hereby given that any interested person may submit 
written comments on the transaction, within fifteen days of the date of 
this publication, to the Associate Administrator for Investment, U.S. 
Small Business Administration, 409 Third Street SW., Washington, DC 
20416.

    Dated: November 30, 2011.
Sean J. Greene,
Associate Administrator for Investment.
[FR Doc. 2011-31548 Filed 12-7-11; 8:45 am]
BILLING CODE 8025-01-P